Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Veterinary Internal Medicine"
DOI: 10.1111/jvim.16341
Abstract: Abstract Background Rabacfosadine (RAB, Tanovea‐CA1) is a novel chemotherapy agent conditionally approved for the treatment of lymphoma in dogs. Hypothesis/Objectives To determine the efficacy and safety of RAB in dogs with lymphoma. Animals One hundred… read more here.
Keywords: dogs lymphoma; placebo; rab; rabacfosadine ... See more keywords